Login
Companies $IMDX
$1.65 -$0.21 (11.29%) Pre-market
Insight Molecular Diagnostics Inc. logo

Insight Molecular Diagnostics Inc.

imdxinc.com

What Do They Do?

Provides laboratory testing and test-development services to life sciences and biotechnology companies. Develops molecular diagnostic tests and kits for hospitals, transplant centers, laboratories and researchers.

How Do They Make Money?

Laboratory Services brings in fees from life sciences customers for assay development, testing and clinical-trial support; services or tests are usually billed when completed, while some customized projects are billed as work progresses. Research-use kits are sold as goods, with revenue counted when they transfer to customers.

revenue
SegmentShareRevenue
Laboratory Services
Sold outright

99%
Laboratory Developed Test Services
0.0%
Kitted Products
Sold outright
0.6%

Who Are Their Customers?

Laboratory Services customers are life sciences and biotechnology companies; the company targets hospitals, transplant centers and labs for its molecular tests.

Customers above 10% of revenue, FY2025
of revenue from one customer
FY2024: 84% from one customer

Do Revenues Turn Into Profits?

No. It lost $50.2M in FY2025.

Operating income, FY2025
−1261% of revenue
▲ +16% (Loss) vs FY2024 (−$61M, −3245%)
Net income, FY2025
−1239% of revenue
▲ +17% (Loss) vs FY2024 (−$60.7M, −3225%)
Free cash flow, FY2025
−626% of revenue
▼ −20% (Loss) vs FY2024 (−$21.2M, −1127%)

How Are They Changing?

Growing. Revenue grew 84% in 4 years, from $2.2M in FY2021 to $4.1M in FY2025, about 17% a year.

Transplant takes priority The older report described oncology and transplant development programs; the latest makes organ transplant the primary near-term market and describes oncology as secondary, with minimal resources and no near-term commercialization plans.

Transplant kits advance The older report described VitaGraft lab testing and planned a research-use kit; the latest describes research and clinical GraftAssure kits, and reports sales of GraftAssureIQ to a research laboratory customer.

Revenue over time
Laboratory Services Laboratory Developed Test Services Kitted Products Pharma Services
$5M$2.5M$0

Who Do They Compete With?

Competes with CareDx, Natera, Transplant Genomics, Omixon, and Devyser

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support